Prostate Adenocarcinoma Clinical Trials
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
P
Recruiting
- Prostate Cancer
- +2 more
- TULSA Procedure
- West Hills, California
- +4 more
2022-04-06
Apr 6, 2022U
Recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
- Aurora, Colorado
- +1 more
2022-04-05
Apr 5, 2022U
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- Prostate Adenocarcinoma
- Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
2022-04-04
Apr 4, 2022E
Recruiting
- Metastatic Prostate Cancer
- Prostate Adenocarcinoma
- Cabozantinib
- +4 more
- Tucson, Arizona
- +232 more
2022-03-28
Mar 28, 2022A
Recruiting
- Prostate Adenocarcinoma
- Niraparib Pill
- Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
2022-03-29
Mar 29, 2022W
Recruiting
- Prostate Adenocarcinoma
- +3 more
- Interview
- Questionnaire Administration
- Phoenix, Arizona
- +324 more
2022-03-29
Mar 29, 2022N
Terminated
- Prostate Cancer
- +6 more
- NanoPac (sterile nanoparticulate paclitaxel) Powder for Suspension
- Tampa, Florida
- +3 more
2022-03-02
Mar 2, 2022J
Active, not recruiting
- Prostate Cancer
- +3 more
- Stereotactic Body Radiation Therapy with Integrated Boost
- Birmingham, AlabamaHazelrig-Salter Radiation Oncology Center
2022-03-25
Mar 25, 2022R
Recruiting
- Prostate Adenocarcinoma
- +9 more
- Angiogram
- +3 more
- San Francisco, CaliforniaUniversity of California San Francisco
2022-03-24
Mar 24, 2022U
Recruiting
- Castration-Sensitive Prostate Carcinoma
- +7 more
- Antiandrogen Therapy
- +3 more
- Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
2022-03-22
Mar 22, 2022U
Not yet recruiting
- Prostate Adenocarcinoma
- Q-Urol
- Placebo
- Salt Lake City, UtahHuntsman Cancer Institute at University of Utah
2022-03-16
Mar 16, 2022C
Recruiting
- Prostate Adenocarcinoma
- Clermont-Ferrand, France
- +5 more
2022-03-14
Mar 14, 2022P
Recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
- Radical Prostatectomy
- TULSA Procedure
- Tarzana, California
- +6 more
2022-03-11
Mar 11, 2022U
Not yet recruiting
- Prostate Cancer
- +3 more
- Abiraterone Oral Tablet
- +3 more
- (no location specified)
2022-03-02
Mar 2, 2022U
Active, not recruiting
- Prostate Cancer
- +3 more
- Ann Arbor, MichiganUniversity of Michigan
2022-03-10
Mar 10, 2022E
Recruiting
- Biochemically Recurrent Prostate Carcinoma
- Prostate Adenocarcinoma
- 3-Dimensional Conformal Radiation Therapy
- +11 more
- Duarte, California
- +35 more
2022-03-09
Mar 9, 2022U
Recruiting
- Biochemically Recurrent Prostate Carcinoma
- +6 more
- Computed Tomography
- +2 more
- Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
2022-03-07
Mar 7, 2022U
Active, not recruiting
- Prostate Adenocarcinoma
- F-18 fluciclovine-PET/CT scan
- Tucson, ArizonaUniversity of Arizona
2022-03-07
Mar 7, 2022A
Active, not recruiting
- Prostate Adenocarcinoma
- Gallium Ga 68-labeled GRPR Antagonist BAY86-7548
- +2 more
- Palo Alto, CaliforniaStanford University, School of Medicine
2022-03-02
Mar 2, 2022L
Recruiting
- Prostate Adenocarcinoma
- +2 more
- Atezolizumab
- +2 more
- San Francisco, California
- +1 more
2022-02-14
Feb 14, 2022S
Not yet recruiting
- Prostate Adenocarcinoma
- +2 more
- radium-223
- Bipolar Androgen Therapy (BAT)
- Baltimore, Maryland
- +1 more
2022-03-02
Mar 2, 2022S
Suspended
- Prostate Adenocarcinoma
- Obesity, Morbid
- Bead Block 300-500 um
- +2 more
- Baltimore, MarylandJohns Hopkins School of Medicine - Sidney Kimmel Comprehensive C
2022-02-14
Feb 14, 2022M
Recruiting
- Prostate Adenocarcinoma
- Illuminare-1
- Karl Storz D-Light C photodynamic diagnostic (PDD)
- Basking Ridge, New Jersey
- +5 more
2022-02-28
Feb 28, 2022N
Active, not recruiting
- Male Breast Carcinoma
- +7 more
- Stereotactic Body Radiation Therapy (SBRT)
- Birmingham, Alabama
- +77 more
2022-02-28
Feb 28, 2022M
Active, not recruiting
- Prostate Adenocarcinoma
- +5 more
- Daratumumab
- +2 more
- Houston, TexasM D Anderson Cancer Center
2022-02-25
Feb 25, 2022